Use of Umbilical Venous Blood on Assessing the Biochemical Variations of Acid–Base, Nutritional and Metabolic Parameters on Growth-Retarded Fetuses, in Comparison with Gestational Control Cases: A Study

Chapter

Abstract

Intra-uterine growth retardation (IUGR) affects 5–10% of pregnancies and carries an increased risk of perinatal mortality and morbidity.1,2 It is suspected when ultrasound examination reveals a fetus who is small for gestational age. However, the general term of IUGR fails to convey the existing heterogeneity of this pathology, whose definition varies according to the length and weight growth curves used, and which etiologies are multiple.

Keywords

Free Fatty Acid Ketone Body Bicarbonate Concentration Fetal Blood Free Fatty Acid Concentration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Starfield B, McCormick M. Mortality and morbidity in infants with intrauterine growth retardation. J Pediatr. 1982;101:978.CrossRefPubMedGoogle Scholar
  2. 2.
    Heinomen K, Matilainen R, Koski H, Launiala K. Intrauterine growth retardation (IUGR) in pre-term infants. J Perinat Med. 1985;13:171-178.CrossRefGoogle Scholar
  3. 3.
    Gluckman PD, Harding JE. The physiology and pathophysiology of intrauterine growth retardation. Horm Res. 1997;48(Suppl):11-16.CrossRefPubMedGoogle Scholar
  4. 4.
    Jones RAK, Roberton NRC. Problems of the small-for-dates baby. Clin Obstet Gynaecol. 1984;11:499-524.PubMedGoogle Scholar
  5. 5.
    Meizner I, Glezerman M. Cordocentesis in the evaluation of the growth-retarded fetus. Clin Obstet Gynecol. 1992;35:126-137.CrossRefPubMedGoogle Scholar
  6. 6.
    Pardi G, Cetin I, Marconi AM, et al. Diagnostic value of blood sampling in fetuses with growth retardation. N Engl J Med. 1993;328:692-696.CrossRefPubMedGoogle Scholar
  7. 7.
    Pardi G, Buscaglia M, Ferrazzi E, et al. Cord sampling for the evaluation of oxygenation and acid-base balance in growth-retarded human fetuses. Am J Obstet Gynecol. 1987;157:1221-1228.PubMedGoogle Scholar
  8. 8.
    Pearce JM, Chamberlain GVP. Ultrasonically guided percutaneous umbilical blood sampling in the management of intra-uterine growth-retardation. Br J Obstet Gynecol. 1987;94:318-321.Google Scholar
  9. 9.
    Weiner CP, Williamson RA. Evaluation of severe growth-retardation using cordocentesis – hematologic and metabolic alteration by etiology. Obstet Gynecol. 1989;73(2):225-229.PubMedGoogle Scholar
  10. 10.
    Ribbert LS, Snijders R, Nicolaides KH, Visser GHA. Relationship of fetal biophysical profile and blood gas values at cordocentesis in severely growth-retarded fetuses. Am J Obstet Gynecol. 1990;163:569-571.PubMedGoogle Scholar
  11. 11.
    Nicolini U, Nicolaidis P, Fisk NM, Vaughan JF, Fusi L, Gleeson R. Limited role of fetal blood sampling in prediction of outcome in intra-uterine growth retardation. Lancet. 1990;336:768-772.CrossRefPubMedGoogle Scholar
  12. 12.
    Hsieh TT, Kuo DM, Lo LM, Chiu TH. The value of cordocentesis in management of patients with severe preeclampsia. Asia-Oceania J Obstet Gynecol. 1991;17(1):89-95.CrossRefGoogle Scholar
  13. 13.
    Economides DL, Nicolaides KH. Blood glucose and oxygen tension levels in small for gestational age fetuses. Am J Obstet Gynecol. 1989;160:385-389.PubMedGoogle Scholar
  14. 14.
    Nicolini U, Hubinont C, Santolaya J, Fisk NM, Rodeck CH. Effects of fetal intravenous glucose challenge in normal and growth-retarded fetuses. Horm Metab Res. 1990;22:426-430.CrossRefPubMedGoogle Scholar
  15. 15.
    Economides DL, Crook D, Nicolaides KH. Investigation of hypertriglyceridemia in small for gestational age fetuses. Fetal Ther. 1988;3:165-172.CrossRefPubMedGoogle Scholar
  16. 16.
    Cetin I, Ronzoni S, Marconi AM, Perugino G, Corbetta C, Battaglia FC. Maternal concentrations and fetal-maternal concentration differences of plasma amino-acids in normal and intra-uterine growth-restricted pregnancies. Am J Obstet Gynecol. 1996;174:1575-1583.CrossRefPubMedGoogle Scholar
  17. 17.
    Lubchenko LO, Hansman C, Dressler M, Boyd E. Intra-uterine growth as estimated from liveborn birth-weight data at 24 to 42 weeks of gestation. Pediatrics. 1963;32:793-800.Google Scholar
  18. 18.
    Daffos F, Capella-Pavlovsky M, Forestier F. Fetal blood sampling via the umbilical cord using a needle guided by ultrasound. Prenat Diagn. 1983;3:271-277.CrossRefPubMedGoogle Scholar
  19. 19.
    Dommergues M, Bunduki V, Muler F, Mandelbrot L, Morichon-Delvallez N, Dumez Y. Serum hCG assay: a method for detection of contamination of fetal blood samples. Prenat Diagn. 1993;13:1043-1046.CrossRefPubMedGoogle Scholar
  20. 20.
    Okabe H, Uji Y, Nagashima K, Noma A. Enzymatic determination of free fatty acids in serum. Clin Chem. 1980;26:1540-1543.PubMedGoogle Scholar
  21. 21.
    Olsen C. An enzymatic fluorimetric micromethod for the determination of aceto-acetate, beta-hydroxybutyrate, pyruvate and lactate. Clin Chem Acta. 1971;33:293-300.CrossRefGoogle Scholar
  22. 22.
    Bon C, Gelineau MC, Raudrant D, Pichot J, Revol A. Fœtal blood human chorionic gonadotropin concentrations in normal and abnormal pregnancies. Immunoanal Biol Spec. 1999;14:37-46.Google Scholar
  23. 23.
    Rizzo G, Montuschi P, Capponi A, Romanini C. Blood levels of vasoactive intestinal polypeptide in normal and growth retarded fetuses: relationship with acid-base and haemodynamic status. Early Hum Dev. 1995;41:69-77.CrossRefPubMedGoogle Scholar
  24. 24.
    Yoneyama Y, Wakatsuki M, Sawa R, et al. Plasma adenosine concentration in appropriate and small for gestational age fetuses. Am J Obstet Gynecol. 1994;170:684-688.PubMedGoogle Scholar
  25. 25.
    Merlet-Benichou C, Leroy B, Gilbert T, Lelièvre-Pegorier M. Retard de croissance intra-utérin et déficit en néphrons. Med Sci (Paris). 1993;9:777-780.Google Scholar
  26. 26.
    Nicolini U, Hubinont C, Santolaya J, Fisk NM, Coe AM, Rodeck CH. Maternal-fetal glucose gradient in normal pregnancies and in pregnancies complicated by alloimmunization and fetal growth retardation. Am J Obstet Gynecol. 1989;161:924-927.PubMedGoogle Scholar
  27. 27.
    Hubinont C, Nicolini U, Fisk NM, Tanninandorm Y, Rodeck CH. Endocrine-pancreatic function in growth-retarded fetuses. Obstet Gynecol. 1991;77(4):541-544.PubMedGoogle Scholar
  28. 28.
    Marconi AM, Cetin I, Davoli E, et al. An evaluation of fetal glucogenesis in intrauterine growth-retarded pregnancies. Metal Clin Exp. 1993;42(7):860-864.Google Scholar
  29. 29.
    Magnusson AL, Powell T, Wennergren M, Jansson T. Glucose metabolism in the human preterm and term placenta of IUGR fetuses. Placenta. 2004;25:337-346.CrossRefPubMedGoogle Scholar
  30. 30.
    Urban J, Iwaszkiewicz-Pawlowska A. Concentration of free fatty acids in amniotic fluid and maternal and cord serum in cases of intrauterine growth retardation. J Perinat Med. 1986;14:259-262.CrossRefPubMedGoogle Scholar
  31. 31.
    Bon C, Raudrant D, Golfier F, et al. Feto-maternal metabolism in human normal pregnancies: study of 73 cases. Ann Biol Clin. 2007;65(6):609-619.Google Scholar
  32. 32.
    Pere MC. Materno-fœtal exchanges and utilisation of nutrients by the fœtus: comparison between species. Reprod Nutr Dev. 2003;43:1-15.CrossRefPubMedGoogle Scholar
  33. 33.
    Battaglia FC, Meschia G. Fetal nutrition. Ann Rev Nutr. 1988;8:43-61.CrossRefGoogle Scholar
  34. 34.
    Hawdon JM, Ward Platt MP. Metabolic adaptation in small for gestational age infants. Arch Dis Child. 1993;68:262-268.CrossRefPubMedGoogle Scholar
  35. 35.
    De Boissieu D, Rocchiccioli F, Kalach N, Bougnères PF. Ketone body turnover at term and in premature newborns in the first two weeks after birth. Biol Neonate. 1995;67:84-93.CrossRefPubMedGoogle Scholar
  36. 36.
    Spencer JAD, Chang TC, Crook D, et al. Third trimester fetal growth and measures of carbohydrate and lipid metabolism in umbilical venous blood at term. Arch Dis Child. 1997;76:21-25.Google Scholar
  37. 37.
    Roberts A, Nava S, Bocconi L, Salmona S, Nicolini U. Liver function tests and glucose and lipid metabolism in growth-retarded fetuses. Obstet Gynecol. 1999;94:290-294.CrossRefPubMedGoogle Scholar
  38. 38.
    Roux C, Wolf C, Mulliez N, Gaona W, Cormier V, Chevy F. Role of cholesterol in embryonic development. Am J Clin Nutr. 2000;71(Suppl 5):1270-1279.Google Scholar
  39. 39.
    Lemery DJ, Beal V, Vanlieferinghen P, Motta C. Fetal blood cell membrane fluidity in small for gestational age fetuses. Biol Neonate. 1993;64:7-12.CrossRefPubMedGoogle Scholar
  40. 40.
    Antsaklis A, Daskalaris G, Papantoniou N, Michalas S. Fetal blood sampling-indication-related losses. Prenat Diagn. 1998;18:934-940.CrossRefPubMedGoogle Scholar

Copyright information

© Springer London 2011

Authors and Affiliations

  1. 1.Department of BiochemistryHôtel Dieu HospitalLyon Cedex 02France

Personalised recommendations